<DOC>
	<DOC>NCT00208455</DOC>
	<brief_summary>The purpose of this study is to monitor the performance of the DePuy PROXIMA™ hip in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments. A subset of patients will undergo scans to allow the bone mineral density of the bone surrounding the implant to be monitored</brief_summary>
	<brief_title>A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Femoral Fractures</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Hip Dislocation, Congenital</mesh_term>
	<criteria>i) Male or female subjects between 18 and 70 years of age. ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained. iii) Subjects who, in the opinion of the Investigator, are able to understand this investigation, cooperate with the investigational procedures and agree to return to the hospital for all the required postoperative followups. iv) Subjects who are scheduled to undergo a primary total hip replacement whom the surgeon considers to be suitable for the DePuy PROXIMA™ hip femoral prosthesis. i) Subjects who, in the opinion of the Investigator, have an existing condition/comorbidity or infection that would compromise their long term participation and followup in this study. ii) Women who are pregnant. iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could affect followup care or treatment outcomes. iv) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s). v) Subjects who are currently involved in any injury litigation claims. vi) Subjects for whom the surgical procedure is a revision of a previous THR or hemiarthroplasty, or who have previously undergone arthrodesis or osteotomy of the hip. vii) Subjects undergoing a simultaneous bilateral hip operation. viii) Subjects undergoing the second stage of a staged bilateral for whom the contralateral hip is part of this clinical investigation. ix) Subjects undergoing the second stage of a staged bilateral for whom the contralateral hip was implanted less than six months previously or is not performing satisfactorily</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Arthroplasty</keyword>
	<keyword>Replacement</keyword>
	<keyword>Hip</keyword>
	<keyword>Conservative</keyword>
	<keyword>Anatomic</keyword>
	<keyword>Cementless</keyword>
</DOC>